Geraldine Sowinski Pinkus, M.D.
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Geraldine Pinkus's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Geraldine Pinkus has written about over time.
Immunoenzyme TechniquesMesotheliomaHodgkin DiseaseMyeloproliferative DisordersLymphoma, Large B-Cell, DiffuseLeukemia, Hairy CellAntigens, CDImmunohistochemistryLymphoma, B-CellDendritic CellsBone MarrowLymphoma, T-CellLeukemia, Megakaryoblastic, AcuteIntegrin alpha ChainsHistiocytic Necrotizing LymphadenitisLeukemia, Monocytic, AcuteHematologic NeoplasmsGATA1 Transcription FactorLymphoma, T-Cell, Peripheral
To see the data from this visualization as text,
click here.
Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
Immunoenzyme Techniques | 48 | 1977 | 2013 | December 1989 |
Mesothelioma | 12 | 1980 | 2014 | May 1994 |
Hodgkin Disease | 29 | 1974 | 2023 | July 1995 |
Myeloproliferative Disorders | 10 | 1977 | 2023 | December 1998 |
Lymphoma, Large B-Cell, Diffuse | 28 | 1973 | 2021 | October 2000 |
Leukemia, Hairy Cell | 5 | 1977 | 2017 | April 2001 |
Antigens, CD | 22 | 1991 | 2016 | December 2003 |
Immunohistochemistry | 59 | 1988 | 2021 | July 2005 |
Lymphoma, B-Cell | 17 | 1991 | 2023 | August 2005 |
Dendritic Cells | 16 | 1987 | 2023 | August 2005 |
Bone Marrow | 21 | 1977 | 2024 | April 2007 |
Lymphoma, T-Cell | 5 | 2002 | 2014 | April 2008 |
Leukemia, Megakaryoblastic, Acute | 2 | 1999 | 2017 | July 2008 |
Integrin alpha Chains | 2 | 2013 | 2014 | December 2013 |
Histiocytic Necrotizing Lymphadenitis | 3 | 2009 | 2021 | June 2015 |
Leukemia, Monocytic, Acute | 2 | 2010 | 2022 | February 2016 |
Hematologic Neoplasms | 4 | 2004 | 2023 | October 2016 |
GATA1 Transcription Factor | 3 | 2017 | 2018 | November 2017 |
Lymphoma, T-Cell, Peripheral | 1 | 2022 | 2022 | February 2022 |